In November, 2017, as part of her long-awaited industrial strategy, UK Prime Minister Theresa May committed to raise investment in research and development (R&D) to 2·4% of gross domestic product by 2027. Life sciences featured prominently in the industrial strategy, described as one of the dominant economic sectors in the UK. A new strategic funding agency—UK Research and Innovation (UKRI)—was created to oversee the allocation of these funds, bringing seven research councils together in a major shake-up of the UK's funding structure.

中文翻译：

---

英国生命科学研究：是时候打破生物医学泡沫了

2017年11月，作为她期待已久的工业战略的一部分，英国首相特蕾莎·梅（Theresa May）承诺到2027年将对研发（R＆D）的投资提高到国内生产总值（GDP）的2·4％。战略，被描述为英国主要的经济部门之一。建立了一个新的战略资助机构，即英国研究与创新局（UKRI），以监督这些基金的分配，将七个研究委员会召集在一起，对英国的资助结构进行了重大调整。